PRODUCT APPLICATIONS: Class I Applications: Currently meeting service standards. Class II Applications (meeting Workload Management eligibility criteria): There are approximately 860 prioritized files in Class II (this includes new […]
On August 7, Health Canada published a technical update to its Science Approach Document (SciAD) on the Bioactivity-Exposure Ratio (BER). The SciAD was originally published for consultation in March […]
On August 12, 2026, the Government of Canada published an Order amending the Domestic Substances List (DSL) in the Canada Gazette, Part II, Volume 160, Number 17. This order represents […]
Cosmetics Alliance Canada is alerting members to a significant increase in the number of CAS Registry Numbers (CAS RNs) identified by Environment and Climate Change Canada (ECCC) in association […]
The Natural and Non-prescription Health Products Directorate (NNHPD) provided an update on the List of Interchangeable Terms. The List of Interchangeable Terms was originally published in November 2025, will […]
Cuminaldehyde: On July 29, 2026, the EU’s Scientific Committee on Consumer Safety (SCCS) was tasked with evaluating the safety of cuminaldehyde as a constituent in natural complex substances used […]
Through the International Cooperation on Cosmetics Regulation (ICCR), global regulators have established a set of general principles designed to foster globally compatible approaches to digital cosmetic labeling. These principles […]
The Consumer Product Safety Program (CPSP) conducted a Compliance Verification project during the 2024–2025 fiscal year to ensure cosmetic products containing eucalyptus oil met the standards of the Food […]
On July 31, 2026, the final five updated monographs, Benzocaine, Figwort, Hawthorn, Marigold extracts and isolates (lutein and zeaxanthin), and Mugwort were published, successfully concluding the monograph revision project […]
The Natural and Non-prescription Health Products Directorate (NNHPD) has developed a new guidance document titled, How to apply for market authorization for a non-prescription drug in Canada. This guidance […]
